1. Home
  2. MCHX vs VIGL Comparison

MCHX vs VIGL Comparison

Compare MCHX & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • VIGL
  • Stock Information
  • Founded
  • MCHX 2003
  • VIGL 2020
  • Country
  • MCHX United States
  • VIGL United States
  • Employees
  • MCHX N/A
  • VIGL N/A
  • Industry
  • MCHX Business Services
  • VIGL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • VIGL Health Care
  • Exchange
  • MCHX Nasdaq
  • VIGL Nasdaq
  • Market Cap
  • MCHX 84.3M
  • VIGL 89.3M
  • IPO Year
  • MCHX 2004
  • VIGL 2022
  • Fundamental
  • Price
  • MCHX $1.99
  • VIGL $2.58
  • Analyst Decision
  • MCHX
  • VIGL Strong Buy
  • Analyst Count
  • MCHX 0
  • VIGL 5
  • Target Price
  • MCHX N/A
  • VIGL $21.00
  • AVG Volume (30 Days)
  • MCHX 28.2K
  • VIGL 2.7M
  • Earning Date
  • MCHX 03-13-2025
  • VIGL 03-25-2025
  • Dividend Yield
  • MCHX N/A
  • VIGL N/A
  • EPS Growth
  • MCHX N/A
  • VIGL N/A
  • EPS
  • MCHX N/A
  • VIGL N/A
  • Revenue
  • MCHX $48,594,000.00
  • VIGL N/A
  • Revenue This Year
  • MCHX N/A
  • VIGL N/A
  • Revenue Next Year
  • MCHX $4.63
  • VIGL N/A
  • P/E Ratio
  • MCHX N/A
  • VIGL N/A
  • Revenue Growth
  • MCHX N/A
  • VIGL N/A
  • 52 Week Low
  • MCHX $1.11
  • VIGL $1.49
  • 52 Week High
  • MCHX $2.40
  • VIGL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 52.44
  • VIGL 66.89
  • Support Level
  • MCHX $1.88
  • VIGL $2.53
  • Resistance Level
  • MCHX $2.06
  • VIGL $2.88
  • Average True Range (ATR)
  • MCHX 0.09
  • VIGL 0.30
  • MACD
  • MCHX -0.00
  • VIGL 0.06
  • Stochastic Oscillator
  • MCHX 75.00
  • VIGL 70.98

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About VIGL Vigil Neuroscience Inc.

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.

Share on Social Networks: